M2Gen Board of Directors

M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of personalized medicines. M2Gen partners with the nation’s leading cancer centers through ORIEN to create a large, cancer-focused data warehouse linking clinical and molecular data. Using this information, M2Gen helps biopharmaceutical companies address the greatest challenges in oncology drug development.

Mr. Theodore J. Couch Sr., Chair

Senator Connie Mack, Vice Chair
Liberty Partners Group

Dr. William Dalton
William S. Dalton, Ph.D., M.D.
CEO, M2Gen; Director, Personalized Medicine Institute, Moffitt Cancer Center

Kenneth Ford, Ph.D.
Founder & CEO, Florida Institute for Human & Machine Cognition

Jack A. Kolosky
Executive Vice President & COOPresident, Moffitt Hospital

Allan Martin
Mr. Allan S. Martin
Founder & Chairman, Atlantic Merchant Capital Investors, LLC

Mr. Kenneth I. Moch

H. Lee Moffitt
The Honorable H. Lee Moffitt
Former Speaker, Florida House of Representatives; Founder, Moffitt Cancer Center 

Ms. Linda Powers
Toucan Capital Fund

Mr. Robert Rothman
President & CEO, Black Diamond Group

Timothy Wright
Mr. Timothy R. Wright
Executive Vice President of Strategy and Global Business DevelopmentTeva Pharmaceuticals